Post-Market Clinical Follow-up (PMCF) Study with the MOBIS II ST cage-implant for transforaminal lumbar fusion (TLIF)

Post-Market Clinical Follow-up (PMCF) Study with the MOBIS II ST cage-implant for transforaminal lumbar fusion (TLIF) - PMCF MOBIS II ST

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00020523

Enrollment

Registered

2020-02-03

Start date

2020-02-08

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the lumbar spine (L1-S1) like degenerative disc diseases, mechanical instability and osteochondrosis. M42.16 M43.16 M43.17 M47.26 M48.06 M51.2 M51.3 M53.26 M47.17

Interventions

Group 1: Patients are before and after the surgery with the MOBIS II ST cage-implant examined and their status is documented. During the examinations, the visual analog scale (VAS), the Oswestry disab

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who are implanted routinely and in accordance with the certification of MOBIS II ST

Exclusion criteria

Exclusion criteria: - Pregnant and breastfeeding women - Patients incapable of giving consent - Younger than 18 years old - Patients without informed consent

Design outcomes

Primary

Measure	Time frame
Bony fusion's rate one year after the surgery in the implanted segement(s)	—

Secondary

Measure	Time frame
- Changes in pain, function and quality of life of the patient bevor and after the surgery (VAS, ODI, SF-12) - Post-operative patient satisfaction (PSI) - Post-operative clinical therapy success - Safety of the implant	—

Countries

Germany

Contacts

Public ContactMelissa Rohde

SRH Wald-Klinikum Gera - Zentrum für klinische Studien

melissa.rohde@srh.de00493658287758

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026